Epinecidin-1 and Its Variants Fight Drug-Resistant Candida Infections
Author Information
Author(s): Jeyarajan Sivakumar, Ranjith Sukumar, Veerapandian Raja, Natarajaseenivasan Kalimuthusamy, Chidambaram Prahalathan, Kumarasamy Anbarasu
Primary Institution: Bharathidasan University, Tiruchirappalli, India
Hypothesis
Can epinecidin-1 and its variants effectively inhibit biofilm formation and growth of drug-resistant Candida species?
Conclusion
Epinecidin-1 and its variants show significant potential as anti-biofilm agents against drug-resistant Candida species.
Supporting Evidence
- The variants of epinecidin-1 showed two- to eight-fold enhancements in activity compared to the original peptide.
- Electron microscopy confirmed that the peptides induce pore formation in Candida cell membranes.
- Peptide treatment significantly reduced biofilm formation in Candida species.
Takeaway
This study shows that special proteins called peptides can help fight off bad germs that cause infections in women, especially those using certain birth control devices.
Methodology
The study used microbroth dilution to measure the minimum inhibitory concentration (MIC) of peptides against Candida species and assessed biofilm formation using crystal violet staining.
Limitations
The study primarily focuses on in vitro results, which may not fully represent in vivo effectiveness.
Participant Demographics
Women aged 20–35 years with signs of pelvic inflammation and vaginal discharge.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website